Kevin has more than 30 years of Quality-related experience spanning from early-stage drug development through numerous drug product approvals across multiple therapeutic areas and delivery systems.
Prior to Atea, Kevin was the President and Founder of ThinkQuality, LLC, a consulting firm that provided strategies and solutions to Quality-related challenges in the life sciences area. Before that, Kevin served as Vice President Quality at Ironwood Pharmaceuticals and Vice President Corporate Quality at Nektar Therapeutics and held global, senior leadership roles in Quality at AstraZeneca. While at Warner-Lambert/Parke-Davis (now Pfizer), Kevin transitioned into a Quality role after beginning his career as a scientist/analytical chemist in the consumer product industry.
Kevin holds a BS in Chemistry from Tufts University and a PhD in Analytical Chemistry from the University of Massachusetts Amherst.Back to Full Team